Lista de obras -

Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.

artículo científico publicado en 2015

Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects

artículo científico publicado en 2016

Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors

artículo científico publicado en 2012

Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms

artículo científico publicado en 2015

Comprehensive Assessment of GPR68 Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody

artículo científico publicado en 2019

Concomitant lung and gastroenteropancreatic neuroendocrine tumors and the value of gallium-68 PET/CT ⬇️

artículo científico publicado el 26 de noviembre de 2011

Correlation of monoclonal and polyclonal somatostatin receptor 5 antibodies in pancreatic neuroendocrine tumors ⬇️

artículo científico publicado el 20 de noviembre de 2012

Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin

scientific article published on 13 March 2019

Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms

artículo científico publicado en 2015

Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.

artículo científico publicado en 2018

Erratum to: Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin

artículo científico publicado en 2017

Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas

artículo científico publicado en 2017

FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors

artículo científico publicado en 2015

High Uptake of 68Ga-DOTATOC in Spleen as Compared to Splenosis: Measurement by PET/CT ⬇️

artículo científico publicado el 1 de enero de 2013

Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment

artículo científico publicado en 2020

Intraoperative somatostatin receptor detection after peptide receptor radionuclide therapy with (177)Lu- and (90)Y-DOTATOC (tandem PRRNT) in a patient with a metastatic neuroendocrine tumor

artículo científico publicado en 2013

Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy

artículo científico publicado en 2015

Localization of Radiolabeled Somatostatin Analogs in the Spleen

artículo científico publicado en 2015

Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases

artículo científico publicado en 2011

Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains

artículo científico publicado en 2016

Mechanisms of targeting the MDM2-p53-FOXM1 axis in well-differentiated intestinal neuroendocrine tumors

artículo científico publicado en 2017

Molecular imaging of late somatostatin receptor-positive metastases of renal cell carcinoma in the pancreas by 68Ga DOTATOC PET/CT: a rare differential diagnosis to multiple primary pancreatic neuroendocrine tumors

artículo científico publicado en 2014

Molecular imaging with ⁶⁸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours.

artículo científico publicado en 2011

Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor

artículo científico publicado en 2009

Nested Stromal Epithelial Tumor of the Liver—Liver Transplantation and Follow-Up ⬇️

artículo científico publicado el 1 de diciembre de 2011

Prior Resection of the Primary Tumor Prolongs Survival After Peptide Receptor Radionuclide Therapy of Advanced Neuroendocrine Neoplasms

artículo científico publicado en 2019

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.

artículo científico publicado en 2017

Radioguided Surgery in Neuroendocrine Tumors Using Ga-68-Labeled Somatostatin Analogs ⬇️

artículo científico publicado el 1 de febrero de 2012

Reassessment of endothelin receptor A expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-8

artículo científico publicado en 2015

Reconstruction of a total avulsion of the hepatic veins and the suprahepatic inferior vena cava secondary to blunt thoracoabdominal trauma

artículo científico publicado en 2010

Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms

artículo científico publicado en 2018

Role of PET/CT in the functional imaging of endocrine pancreatic tumors

artículo científico

Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets

artículo científico publicado en 2017

Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer

artículo científico publicado en 2018

Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours

artículo científico publicado en 2019

Somatostatin receptor immunohistochemistry in neuroendocrine tumors: comparison between manual and automated evaluation

artículo científico publicado en 2014

Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers.

artículo científico publicado en 2014

Lista de obras de

Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.

Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects

Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors

Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms

Comprehensive Assessment of GPR68 Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody

Concomitant lung and gastroenteropancreatic neuroendocrine tumors and the value of gallium-68 PET/CT ⬇️

Correlation of monoclonal and polyclonal somatostatin receptor 5 antibodies in pancreatic neuroendocrine tumors ⬇️

Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin

Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms

Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.

Erratum to: Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin

Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas

FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors

High Uptake of 68Ga-DOTATOC in Spleen as Compared to Splenosis: Measurement by PET/CT ⬇️

Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment

Intraoperative somatostatin receptor detection after peptide receptor radionuclide therapy with (177)Lu- and (90)Y-DOTATOC (tandem PRRNT) in a patient with a metastatic neuroendocrine tumor

Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy

Localization of Radiolabeled Somatostatin Analogs in the Spleen

Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases

Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains

Mechanisms of targeting the MDM2-p53-FOXM1 axis in well-differentiated intestinal neuroendocrine tumors

Molecular imaging of late somatostatin receptor-positive metastases of renal cell carcinoma in the pancreas by 68Ga DOTATOC PET/CT: a rare differential diagnosis to multiple primary pancreatic neuroendocrine tumors

Molecular imaging with ⁶⁸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours.

Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor

Nested Stromal Epithelial Tumor of the Liver—Liver Transplantation and Follow-Up ⬇️

Prior Resection of the Primary Tumor Prolongs Survival After Peptide Receptor Radionuclide Therapy of Advanced Neuroendocrine Neoplasms

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.

Radioguided Surgery in Neuroendocrine Tumors Using Ga-68-Labeled Somatostatin Analogs ⬇️

Reassessment of endothelin receptor A expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-8

Reconstruction of a total avulsion of the hepatic veins and the suprahepatic inferior vena cava secondary to blunt thoracoabdominal trauma

Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms

Role of PET/CT in the functional imaging of endocrine pancreatic tumors

Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets

Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer

Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours

Somatostatin receptor immunohistochemistry in neuroendocrine tumors: comparison between manual and automated evaluation

Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers.